FluoGuide awarded post doc grant to expand the pipeline
Copenhagen, Denmark, 26 October 2020 - FluoGuide A/S (“FluoGuide” or “the Company”) is pleased to announce that Innovation Fund Denmark has awarded FluoGuide DKK 1.2 million to a 3-year post doc position for Karina Juhl to explore a complementary class of products to guide oncology surgery.
Karina Juhl has been participating in the preclinical experiments supporting development of FG001 for guiding surgery of glioblastoma. Following her academic PhD position, she will now join FluoGuide as a post doc researcher in a collaboration with University of Copenhagen. Innovation Fund Denmark has in this relation awarded support of DKK 1.2 million.
“I am always pleased to see that talented people from my group are being recognized for excellent research that is turned into technologies and products that can help patients fighting cancer”, says Professor Andreas Kjær, CSO in FluoGuide.
FluoGuide A/S is obliged to publish this information in accordance with the EU Market Abuse Regulation. The information was provided by the contact person set out above for publication on 26 October 2020.
For further information:
Morten Albrechtsen, CEO
M: +45 24 25 62 66
FluoGuide’s primary focus is to maximize surgical outcomes in oncology. The Company’s first product, FG001, is designed to improve surgical precision by illuminating cancer cells intraoperatively. The improved precision enabled by FluoGuide’s products has a dual benefit – it reduces both the frequency of local recurrence post-surgery and lessens surgical sequelae. Ultimately, these improvements will improve a patient’s chance of achieving a complete cure and will lower system-wide healthcare costs. The Company is undertaking a proof-of-concept clinical trial (phase I/II) to demonstrate the effect of FG001 in patients with high grade glioma including glioblastoma.
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 954904.